News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
741,403 Results
Type
Article (43792)
Company Profile (318)
Press Release (697280)
Multimedia
Podcasts (115)
Webinars (19)
Section
Business (211006)
Career Advice (2108)
Deals (36758)
Drug Delivery (123)
Drug Development (83405)
Employer Resources (176)
FDA (16816)
Job Trends (15505)
News (357361)
Policy (34126)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2615)
Accelerated approval (31)
Adcomms (26)
Allergies (143)
Alliances (51591)
ALS (171)
Alzheimer's disease (1680)
Antibody-drug conjugate (ADC) (318)
Approvals (17076)
Artificial intelligence (523)
Autoimmune disease (146)
Automation (37)
Bankruptcy (372)
Best Places to Work (11776)
BIOSECURE Act (21)
Biosimilars (193)
Biotechnology (188)
Bladder cancer (157)
Brain cancer (59)
Breast cancer (642)
Cancer (4828)
Cardiovascular disease (410)
Career advice (1787)
Career pathing (36)
CAR-T (279)
CDC (47)
Celiac Disease (2)
Cell therapy (742)
Cervical cancer (36)
Clinical research (71080)
Collaboration (1723)
Company closure (4)
Compensation (1150)
Complete response letters (60)
COVID-19 (2782)
CRISPR (93)
C-suite (837)
Cystic fibrosis (148)
Data (6191)
Decentralized trials (2)
Denatured (36)
Depression (133)
Diabetes (501)
Diagnostics (6756)
Digital health (44)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (249)
Drug pricing (202)
Drug shortages (31)
Duchenne muscular dystrophy (228)
Earnings (91767)
Editorial (58)
Employer branding (21)
Employer resources (154)
Events (120162)
Executive appointments (984)
FDA (19926)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (23)
Funding (1462)
Gene editing (199)
Generative AI (44)
Gene therapy (603)
GLP-1 (1009)
Government (4793)
Grass and pollen (7)
Guidances (384)
Healthcare (19063)
HIV (55)
Huntington's disease (45)
IgA nephropathy (83)
Immunology and inflammation (256)
Immuno-oncology (54)
Indications (104)
Infectious disease (3041)
Inflammatory bowel disease (192)
Inflation Reduction Act (14)
Influenza (110)
Intellectual property (247)
Interviews (326)
IPO (16918)
IRA (56)
Job creations (4070)
Job search strategy (1499)
JPM (63)
Kidney cancer (15)
Labor market (83)
Layoffs (574)
Leadership (32)
Legal (8421)
Liver cancer (92)
Longevity (15)
Lung cancer (647)
Lymphoma (374)
Machine learning (43)
Management (60)
Manufacturing (805)
MASH (166)
Medical device (13844)
Medtech (13896)
Mergers & acquisitions (20899)
Metabolic disorders (1286)
Multiple sclerosis (156)
NASH (17)
Neurodegenerative disease (314)
Neuropsychiatric disorders (89)
Neuroscience (2915)
Neurotech (1)
NextGen: Class of 2026 (6648)
Non-profit (4559)
Now hiring (65)
Obesity (608)
Opinion (282)
Ovarian cancer (165)
Pain (214)
Pancreatic cancer (224)
Parkinson's disease (281)
Partnered (34)
Patents (494)
Patient recruitment (476)
Peanut (58)
People (60856)
Pharmaceutical (90)
Pharmacy benefit managers (31)
Phase 1 (22066)
Phase 2 (31254)
Phase 3 (23422)
Pipeline (5128)
Policy (294)
Postmarket research (2655)
Preclinical (9378)
Press Release (68)
Prostate cancer (236)
Psychedelics (49)
Radiopharmaceuticals (283)
Rare diseases (848)
Real estate (6307)
Recruiting (71)
Regulatory (25318)
Reports (51)
Research institute (2435)
Resumes & cover letters (360)
Rett syndrome (27)
RNA editing (17)
RSV (76)
Schizophrenia (154)
Series A (243)
Series B (187)
Service/supplier (11)
Sickle cell disease (98)
Special edition (24)
Spinal muscular atrophy (160)
Sponsored (42)
Startups (3764)
State (2)
Stomach cancer (18)
Supply chain (106)
Tariffs (96)
The Weekly (77)
Vaccines (1013)
Venture capital (88)
Weight loss (400)
Women's health (87)
Worklife (18)
Date
Today (22)
Last 7 days (609)
Last 30 days (1991)
Last 365 days (30230)
2026 (2874)
2025 (30679)
2024 (35769)
2023 (40630)
2022 (51804)
2021 (56336)
2020 (54800)
2019 (47423)
2018 (35790)
2017 (33137)
2016 (32683)
2015 (38631)
2014 (32523)
2013 (27639)
2012 (29740)
2011 (30493)
2010 (28500)
Location
Africa (802)
Alabama (83)
Alaska (7)
Arizona (312)
Arkansas (14)
Asia (42132)
Australia (6744)
California (11221)
Canada (3274)
China (1122)
Colorado (474)
Connecticut (471)
Delaware (336)
Europe (90266)
Florida (1669)
Georgia (353)
Hawaii (3)
Idaho (61)
Illinois (869)
India (65)
Indiana (523)
Iowa (22)
Japan (429)
Kansas (125)
Kentucky (38)
Louisiana (26)
Maine (72)
Maryland (1379)
Massachusetts (8086)
Michigan (322)
Minnesota (626)
Mississippi (5)
Missouri (125)
Montana (31)
Nebraska (28)
Nevada (122)
New Hampshire (78)
New Jersey (2987)
New Mexico (29)
New York (2963)
North Carolina (1460)
North Dakota (8)
Northern California (5457)
Ohio (331)
Oklahoma (22)
Oregon (46)
Pennsylvania (2271)
Puerto Rico (22)
Rhode Island (47)
South America (1175)
South Carolina (66)
South Dakota (1)
Southern California (4368)
Tennessee (172)
Texas (1737)
United States (39910)
Utah (336)
Vermont (1)
Virginia (272)
Washington D.C. (81)
Washington State (923)
West Virginia (4)
Wisconsin (111)
Wyoming (2)
741,403 Results for "elite pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Policy
Elite Pharmaceuticals Receives FDA Approval for Generic Methotrexate
Elite Pharmaceuticals, Inc. announced that it received approval from the US Food and Drug Administration for an Abbreviated New Drug Application for generic Methotrexate Sodium 2.5 mg tablets.
May 20, 2024
·
2 min read
Press Releases
Neuronetics Announces Three-Year Exclusive Partnership with Elite DNA Behavioral Health to Expand NeuroStar Access and Operational Excellence
October 31, 2025
·
7 min read
Press Releases
Aucta Pharmaceuticals, Inc. (“Aucta Pharmaceuticals”) prepares for the launch of PYQUVI™ (deflazacort) oral suspension, the first of a new branded-generic rare disease product line
February 8, 2026
·
7 min read
Business
Elite Pharmaceuticals, Inc. Reports Financial Results for Third Quarter of Fiscal Year 2024 ended December 31, 2023 and Provides Conference Call Information
Elite Pharmaceuticals, Inc. announced results for the third quarter of fiscal year 2024 ended December 31, 2023.
February 14, 2024
·
3 min read
Pharm Country
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2024 Financial Results on February 15, 2024
Elite Pharmaceuticals, Inc. announced today that the third quarter financial results of the 2024 fiscal year will be released on Wednesday, February 14, 2024.
February 8, 2024
·
2 min read
Press Releases
60 Degrees Pharmaceuticals, Inc. Announces Approval of Reverse Stock Split Ratio
January 16, 2026
·
6 min read
Press Releases
China SXT Pharmaceuticals Inc. Announces $10 Million Registered Direct Offering
January 12, 2026
·
3 min read
Business
Elite Pharmaceuticals, Inc. Appoints Carter Ward as Chief Financial Officer
Elite Pharmaceuticals, Inc., a specialty pharmaceutical company developing and manufacturing niche generic products, announced the appointment of Carter Ward as its Chief Financial Officer, effective September 5, 2023.
September 7, 2023
·
3 min read
Business
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Second Quarter 2024 Financial Results on November 15, 2023
Elite Pharmaceuticals, Inc. (“Elite” or the “Company”) (OTCBB:ELTP), a specialty pharmaceutical company developing niche generic products, announced today that the second quarter financial results of the 2024 fiscal year will be released on Tuesday, November 14, 2023.
November 10, 2023
·
2 min read
Press Releases
CHINA SXT PHARMACEUTICALS, INC. ANNOUNCES STRATEGIC INITIATIVE TO APPLY AI TECHNOLOGY ACROSS THE TCM SUPPLY CHAIN
January 16, 2026
·
3 min read
1 of 74,141
Next
